Skip to main content

Table 1 5'-aza-deoxycytidine induced re-activation of NK2-3 gene expression in ovarian cancer cell lines

From: DNA methylation changes in ovarian cancer are cumulative with disease progression and identify tumor stage

cell line dose 5'-aza-dC (uM) fold increase over untreated control cells
ES2 2 1.3
ES2 10 7.2
OVCAR3 2 55
OVCAR3 10 359